ArticleOncotarget2015

Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.

Meiyuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.